Azithromycin Use and Increased Cancer Risk among Patients with Bronchiolitis Obliterans after Hematopoietic Cell Transplantation

Guang‐Shing Cheng(Fred Hutch Cancer Center), Anne Bergeron(Délégation Paris 7), Mary E.D. Flowers(City Of Hope National Medical Center), Ted Gooley(Fred Hutch Cancer Center), Qianchuan He(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), David Michonneau(Inserm), Kareem Jamani(Fred Hutch Cancer Center), Sylvie Chevret(Université Paris Cité), Elizabeth F. Krakow(Fred Hutch Cancer Center), Régis Peffault de Latour(European Molecular Biology Laboratory), Louise Bondeelle(Université Paris Cité), Jason W. Chien(Gilead Sciences (United States)), Gèrard Socié(Hôpital Saint-Louis)
Biology of Blood and Marrow Transplantation
November 3, 2019
10.1016/j.bbmt.2019.10.025
Cited by 39

Related Papers

National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group Report
|Biology of Blood and Marrow Transplantation|2014|5.4k
HLA-Haploidentical Bone Marrow Transplantation for Hematologic Malignancies Using Nonmyeloablative Conditioning and High-Dose, Posttransplantation Cyclophosphamide
|Biology of Blood and Marrow Transplantation|2008|1.9k
Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus-tumor effects
|Blood|2001|1.4k
Transfusion independence and HMGA2 activation after gene therapy of human β-thalassaemia
|Nature|2010|1.3k
The Complement Inhibitor Eculizumab in Paroxysmal Nocturnal Hemoglobinuria
|New England Journal of Medicine|2006|1.3k